Ambica Agarbathies Aroma & Industries Limited (AMBICAAGAR.BO)
INR 27.22
(0.48%)
INR 27.22
(0.48%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.09 Billion INR | 11.24% |
| 2022 | 988.69 Million INR | -15.29% |
| 2021 | 1.16 Billion INR | 4.7% |
| 2020 | 1.11 Billion INR | 4.04% |
| 2019 | 1.07 Billion INR | 5.82% |
| 2018 | 1.01 Billion INR | -13.08% |
| 2017 | 1.16 Billion INR | 51.78% |
| 2016 | 767.45 Million INR | 2.53% |
| 2015 | 748.48 Million INR | 1.65% |
| 2014 | 736.35 Million INR | -15.01% |
| 2013 | 866.44 Million INR | 0.24% |
| 2012 | 864.38 Million INR | 16.45% |
| 2011 | 742.27 Million INR | 18.35% |
| 2010 | 627.2 Million INR | 21.05% |
| 2009 | 518.14 Million INR | -3.12% |
| 2008 | 534.81 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.11 Billion INR | 0.0% |
| 2023 Q4 | 1.09 Billion INR | 0.0% |
| 2022 Q2 | 1.27 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 988.69 Million INR | 0.0% |
| 2022 FY | 988.69 Million INR | -15.29% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 995.37 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.16 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 1.16 Billion INR | 4.7% |
| 2020 FY | 1.11 Billion INR | 4.04% |
| 2020 Q4 | 1.11 Billion INR | 0.0% |
| 2020 Q2 | 1.22 Billion INR | 0.0% |
| 2019 FY | 1.07 Billion INR | 5.82% |
| 2019 Q2 | 1.01 Billion INR | 0.0% |
| 2019 Q4 | 1.07 Billion INR | 0.0% |
| 2018 Q2 | 1.08 Billion INR | 0.0% |
| 2018 FY | 1.01 Billion INR | -13.08% |
| 2018 Q4 | 1.01 Billion INR | 0.0% |
| 2017 FY | 1.16 Billion INR | 51.78% |
| 2017 Q2 | 760.48 Million INR | 0.0% |
| 2017 Q4 | 1.16 Billion INR | 0.0% |
| 2016 Q4 | 767.45 Million INR | 0.0% |
| 2016 FY | 767.45 Million INR | 2.53% |
| 2015 Q4 | 748.48 Million INR | 0.0% |
| 2015 Q2 | 721.63 Million INR | 0.0% |
| 2015 FY | 748.48 Million INR | 1.65% |
| 2014 FY | 736.35 Million INR | -15.01% |
| 2014 Q2 | 787.33 Million INR | 0.0% |
| 2014 Q4 | 736.35 Million INR | 0.0% |
| 2013 Q4 | 866.44 Million INR | 0.0% |
| 2013 FY | 866.44 Million INR | 0.24% |
| 2013 Q2 | 796.71 Million INR | 0.0% |
| 2012 Q4 | 864.38 Million INR | 0.0% |
| 2012 Q2 | 876.34 Million INR | 0.0% |
| 2012 FY | 864.38 Million INR | 16.45% |
| 2011 Q4 | 742.27 Million INR | 0.0% |
| 2011 FY | 742.27 Million INR | 18.35% |
| 2010 FY | 627.2 Million INR | 21.05% |
| 2009 FY | 518.14 Million INR | -3.12% |
| 2008 Q4 | 534.81 Million INR | 0.0% |
| 2008 FY | 534.81 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -3755.167% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | 28.118% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 91.682% |
| Cupid Limited | 186.52 Million INR | -489.624% |
| Dabur India Limited | 48.19 Billion INR | 97.718% |
| Emami Limited | 8.21 Billion INR | 86.62% |
| Gillette India Limited | 8.59 Billion INR | 87.204% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 98.135% |
| Hindustan Unilever Limited | 270.76 Billion INR | 99.594% |
| Hipolin Limited | 48.57 Million INR | -2164.225% |
| Honasa Consumer Limited | 5.36 Billion INR | 79.511% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | -304.776% |
| Jyothy Labs Limited | 5.9 Billion INR | 81.382% |
| Kaya Limited | 5.22 Billion INR | 78.941% |
| Marico Limited | 32.52 Billion INR | 96.618% |
| N.K Industries Limited | 22.4 Billion INR | 95.091% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | -570.738% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | -434.598% |
| Pee Cee Cosma Sope Limited | 80.17 Million INR | -1271.683% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 89.851% |